| 2006 | | Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes. | 김혜진 |
| 2007 | | Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model. | 김대중, 김혜진, 이관우 |
| 2012 | | Deregulation of CREB signaling pathway induced by chronic hyperglycemia downregulates NeuroD transcription | 김성수, 서해영, 이영돈 |
| 2011 | | Detection of differential proteomes associated with the development of type 2 diabetes in the Zucker rat model using the iTRAQ technique. | 강엽 |
| 2014 | | Diabetes burden and prevention in Korea and the Western Pacific Region. | 조남한 |
| 2014 | | Diabetes in the Western Pacific Region--past, present and future. | 조남한 |
| 2020 | | Diabetic polyneuropathy and the risk of developing carpal tunnel syndrome: A nationwide, population-based study | 신재용 |
| 2017 | | Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy | 문가영, 이기황, 임홍석, 정유리 |
| 2011 | | Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic Korean population. | 박진선, 신준한, 탁승제 |
| 2017 | | Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus: A Population-Based Cohort Study | 김대중, 김혜진, 박래웅, 윤덕용, 이관우, 한승진 |
| 2018 | | Dipeptidyl Peptidase-4 Inhibitors and the Risk of Pancreatitis in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study | 김대중, 김혜진, 이관우, 한승진 |
| 2012 | | Direct medical costs for patients with type 2 diabetes and related complications: a prospective cohort study based on the Korean National Diabetes Program | 김대중, 김혜진, 이관우, 전기홍, 한승진 |
| 2022 | | Drug Repositioning Using Temporal Trajectories of Accompanying Comorbidities in Diabetes Mellitus | 전자영 |
| 2021 | | e-Health Interventions for Community-Dwelling Type 2 Diabetes: A Scoping Review | 신승수 |
| 2015 | | Early menarche increases the risk of Type 2 diabetes in young and middle-aged Korean women. | 이해상, 황진순 |
| 2016 | | Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea | 김대중 |
| 2024 | | Effect of motivated physicians and elderly patients with hypertension or type 2 diabetes mellitus in prepared communities on health behaviours and outcomes: A population-based PS matched retrospective cohort study during five-year follow-up period | 이순영 |
| 2017 | | Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes | 강두경, 김혜진, 한승진 |
| 2015 | | Effect of sulodexide in patients with non-proliferative diabetic retinopathy: diabetic retinopathy sulodexide study (DRESS). | 송지훈 |
| 2021 | | Effect of teneligliptin versus sulfonylurea on major adverse cardiovascular outcomes in people with type 2 diabetes mellitus: A real-world study in Korea | 김대중, 하경화 |
| 2021 | | Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A nationwide population-based study | 김대중, 이나미, 하경화, 한승진 |
| 2011 | | Effects of a cardiovascular risk reduction intervention with psychobehavioral strategies for Korean adults with type 2 diabetes and metabolic syndrome. | 김대중 |
| 2017 | | Effects of combination of change in visceral fat and thigh muscle mass on the development of type 2 diabetes | 한승진 |
| 2021 | | Effects of community-based interventions on medication adherence and hospitalization for elderly patients with type 2 diabetes at primary care clinics in South Korea | 이순영 |
| 2023 | | Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study | 이관우 |
| 2017 | | Effects of foot complications in patients with Type 2 diabetes mellitus on public healthcare: An analysis based on the Korea National Diabetes Program Cohort | 이관우, 전기홍 |
| 2007 | | Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. | 김대중, 이관우 |
| 2019 | | Effects of sarpogrelate on microvascular complications with type 2 diabetes | 김대중, 박인휘 |
| 2017 | | Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study | 김대중, 김혜진, 이관우, 한승진 |
| 2023 | | Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension | 김혜진 |
| 2017 | | Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study) | 이관우 |
| 2018 | | Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial | 이관우 |
| 2024 | | Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial | 김범택 |
| 2019 | | Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial | 이관우 |
| 2023 | | Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study | 김대중, 하경화 |
| 2023 | | Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia | 김대중, 하경화 |
| 2023 | | Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study | 김대중, 하경화 |
| 2021 | | Eruptive Xanthoma with Dermal Mucin Deposition | 김유찬 |
| 2020 | | Estimated Association Between Cytokines and the Progression to Diabetes: 10-year Follow-Up From a Community-Based Cohort | 조남한 |
| 2022 | | Experiences of Using Wearable Continuous Glucose Monitors in Adults With Diabetes: A Qualitative Descriptive Study | 김춘자 |
| 2022 | | Factors associated with motor severity in vascular parkinsonism with normal dopamine transporter imaging | 박동규, 윤정한 |
| 2018 | | Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program | 김대중, 김혜진, 이관우, 전자영, 한승진 |
| 2011 | | Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment. | 김혜진 |
| 2013 | | Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India. | 조남한 |
| 2023 | | Genome-Wide Association Study on Longitudinal Change in Fasting Plasma Glucose in Korean Population | 조남한 |
| 2014 | | Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. | 조남한 |
| 2023 | | Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2004 | | Glucose uptake-stimulatory activity of Amomi Semen in 3T3-L1 adipocytes. | 강엽 |
| 2018 | | Glycated hemoglobin A1c as a screening test for detecting type 2 diabetes mellitus in obese children and adolescents | 이해상, 황진순 |
| 2022 | | Healthcare resource utilization in patients treated with empagliflozin in East Asia | 김대중, 하경화 |
| 2011 | | Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study | 조남한 |
| 2000 | | HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. | 김현만, 정윤석 |
| 2019 | | Hospital-Based Korean Diabetes Prevention Study: A Prospective, Multi-Center, Randomized, Open-Label Controlled Study | 이관우 |
| 2020 | | Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study | 김대중, 김혜진, 문소영, 이관우, 전자영, 한승진 |
| 2020 | | Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125-33) | 한승진 |
| 2016 | | Hypoglycemia and Medical Expenses in Patients with Type 2 Diabetes Mellitus: An Analysis Based on the Korea National Diabetes Program Cohort | 이관우 |
| 2016 | | Hypoglycemia is associated with dementia in elderly patients with type 2 diabetes mellitus: An analysis based on the Korea National Diabetes Program Cohort | 이관우, 전기홍 |
| 2024 | | Impact of diabetes distress on glycemic control and diabetic complications in type 2 diabetes mellitus | 이관우 |
| 2020 | | Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism | 이해상, 황진순 |
| 1995 | | Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. | 조남한 |
